Zydus Lifesciences gets USFDA nod for generic product

The approval granted by the US Food and Drug Administration (USFDA) is for Cyanocobalamin injection in strengths of 1,000 mcg/ml, 10,000 mcg/10 ml and 30,000 mcg/30 ml multiple-dose vials, the company said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gJK8XwD
via IFTTT